Scioto County Medical Society Grand Rounds March 31, 2006 Portsmouth, Ohio Kathleen M. Koechlin, RN, MPH, PhD Hepatitis C Coordinator The Ohio Department.

Slides:



Advertisements
Similar presentations
Supplement to HIV and AIDS Surveillance (SHAS). Introduction SHAS was a CDC-funded project designed to provide an in depth description of people diagnosed.
Advertisements

Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
DR. LAURIE DILL, M.D. MEDICAL DIRECTOR, MEDICAL AIDS OUTREACH OF ALABAMA The President’s Advisory Council on HIV/AIDS February 28, 2012 Access to Care.
HIV/AIDS Prevalence & Mortality Report, 2010 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
Hepatitis B: Epidemiology
Hepatitis C In Alaska’s Department of Corrections
Blood and Airborne Pathogens HIV/AIDS/STDs/HepatitisTB/SARS/Influenza.
Epidemiology of hepatitis B in Ireland Updated August 2014
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
HIV/AIDS Prevention Committee Public Meeting November 21, 2013.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
Wisconsin Department of Health Services
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Illustrating HIV/AIDS in the United States African American University Treatment and Science College Training Alexandra Ricca, MPH Emory University Friday,
Emerging Trends of HIV/AIDS in New York City Chris Williams, MPH NYC DOHMH.
Chronic Hepatitis B Surveillance Kathleen Harriman California Department of Public Health Immunization Branch November 1, 2012.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Hepatitis A, B, C Direct Inoculation
Surveillance to measure impact of ART Theresa Diaz, MD MPH CDC Global AIDS Program.
Poverty and the HIV Health Disparity The Season for Change Advent Study Week Two.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.
HBV and HCV: America’s Hidden Epidemics Jeffrey Levi, PhD Trust for America’s Health October 14, 2010.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.
Gonorrhea Epidemiology & Prevention Program Efforts in Ohio Region V Gonorrhea Control Meeting February 2, 2010 Jen Keagy, MPH, CHES STD Program Manager.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
Grace Van Ness, MPH, CHES, Ann Thomas, MD, MPH & Sharon Vance
Sexually Transmitted Infections Mysheika Williams Roberts, MD, MPH Medical Director Assistant Health Commissioner Columbus.
eHARS to CAREWare Pilot Project Update and Training
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
Gonorrhea Increases In Washington State: Gonorrhea Increases In Washington State: Analyses for intervention planning May 2011 Mark R. Stenger Infectious.
Epidemiology Applications Fran C. Wheeler, Ph.D School of Public Health University of South Carolina Columbia, SC (803)
00002-E-1 – 1 December 2002 The AIDS Pandemic: an Update on the Numbers and Needs l What are the numbers for 2002? l What are the global and regional trends?
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
HIV AIDS Africa’s Pandemic?
2007 Viral Hepatitis Data. Data Limitations Morbidity based on reported positive lab result Morbidity based on reported positive lab result –Under-reporting.
TB, STDs, HIV, HEPATITIS C and SUBSTANCE ABUSE: A Local Perspective Paula Kriner, MPH Imperial County Public Health Department Management of TB, STDs,
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
Data Limitations Morbidity based on reported positive lab result –Under-reporting of both acute and chronic infections Morbidity based on CDC case definitions.
Pennsylvania: The State of HCV 2015
Sexually Transmitted Disease (STD) Surveillance Report, 2013 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
STIs (sexually transmitted infections) in the geriatric population
Jessica Carag MS Candidate Public Health Microbiology & Emerging Infectious Diseases Milken Institute School of Public Health The George Washington University.
Trends in Neisseria gonorrhoeae Incidence in Washington State Region X GC Meeting Trends in Neisseria gonorrhoeae Incidence in Washington State Region.
Improving Community Health through Planning and Partnerships Louisa Community Health Council.
Communicable Diseases Alan J. Parkinson, Deputy Director Arctic Investigations Program, Centers for Disease Control & Prevention, USA.
| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
Hepatitis C Virus Program in Chicago
Indiana State Cancer Registry
Needle Exchange Update
Hepatitis C Incidence and Prevalence in the U.S.
Table 1: NHBS HET3 Participant Characteristics
HIV Prevention Data Amanda Dennison, MPH Ohio Department of Health
Latest update to the National Outbreak Response group on recent trends in HIV, STIs and Hepatitis among men who have sex with men (MSM) in Ireland June.
Note: 2017 data are provisional
HEPATITIS C BY MBBSPPT.COM
Hepatitis C Tennessee Caring Ambassadors, Senate Briefing May 18, 2018
SCHS and Health Statistics
M Javanbakht, S Guerry, LV Smith, P Kerndt
Presentation transcript:

Scioto County Medical Society Grand Rounds March 31, 2006 Portsmouth, Ohio Kathleen M. Koechlin, RN, MPH, PhD Hepatitis C Coordinator The Ohio Department of Health

The Epidemiology of Hepatitis C Worldwide: Worldwide: Approximately 180 million people (3.0% of the world population) are infected with HCV. Approximately 180 million people (3.0% of the world population) are infected with HCV. Approximately 130 million are chronic carriers. Approximately 130 million are chronic carriers. Approximately 3-4 million people are newly infected each year. Approximately 3-4 million people are newly infected each year. 70% of these will develop chronic HCV. 70% of these will develop chronic HCV. HCV is responsible for 50-76% of all liver cancer cases and 2/3 of all liver transplants in the developed world. HCV is responsible for 50-76% of all liver cancer cases and 2/3 of all liver transplants in the developed world.

Countries with low disease prevalence (<1%): Countries with low disease prevalence (<1%): Australia Australia Canada Canada Northern Europe Northern Europe Countries with moderate disease prevalence (around 1%): Countries with moderate disease prevalence (around 1%): United States United States Europe Europe Countries with high disease prevalence (>2% and many times as high as 5-10%): Countries with high disease prevalence (>2% and many times as high as 5-10%): Africa Africa Latin America Latin America Central and Southeastern Asia Central and Southeastern Asia Countries with extremely high disease prevalence: Countries with extremely high disease prevalence: Nile delta of Egypt (up to 60% in 30 year olds) Nile delta of Egypt (up to 60% in 30 year olds) x2.html#disease%20burden

Hepatitis C Virus Infection, United States New infections per year , ,000 Deaths from acute liver failureRare Persons ever infected (1.8%)3.9 million ( )* Persons with chronic infection2.7 million ( )* HCV-related chronic liver disease40% - 60% Deaths from chronic disease/year8,000-10,000 *95% Confidence Interval

Hepatitis C in Ohio

The hepatitis registry was established in 2001 using tobacco industry settlement funds. The hepatitis registry was established in 2001 using tobacco industry settlement funds. The purpose of this registry is to provide population based data that accurately describes hepatitis C in Ohio. The purpose of this registry is to provide population based data that accurately describes hepatitis C in Ohio. This information is used to target resources for planning and evaluating hepatitis prevention, treatment, and service programs in the state. This information is used to target resources for planning and evaluating hepatitis prevention, treatment, and service programs in the state.

Every Ohio county has reported at least one hepatitis C diagnosis. Every Ohio county has reported at least one hepatitis C diagnosis. As of September 30, 2005, the hepatitis registry contained over 48,000 cases, of which just under 40.0% are confirmed hepatitis C diagnoses. The other 60.0% are potential diagnoses that are being investigated. As of September 30, 2005, the hepatitis registry contained over 48,000 cases, of which just under 40.0% are confirmed hepatitis C diagnoses. The other 60.0% are potential diagnoses that are being investigated. Approximately 500 reports of potential hepatitis diagnoses are received by hepatitis surveillance each week. These reports include new cases and updates to cases under investigation. Approximately 500 reports of potential hepatitis diagnoses are received by hepatitis surveillance each week. These reports include new cases and updates to cases under investigation.

Of all cases in the hepatitis registry, 64.8% are male, and 59.2% are ages 40 to 59 years. Of all cases in the hepatitis registry, 64.8% are male, and 59.2% are ages 40 to 59 years. Nearly 70% of reported hepatitis cases are lacking race information. Nearly 70% of reported hepatitis cases are lacking race information. Quarterly and annual summary statistics are compiled from the cleaned data and released for public use on the ODH website. Quarterly and annual summary statistics are compiled from the cleaned data and released for public use on the ODH website.

Challenges in Reporting Demographic information Demographic information Source: ODH Hepatitis Surveillance Program.

Challenges in Reporting Risk factor information Risk factor information Source: ODH Hepatitis Surveillance Program.

Importance of Complete Reporting Determine who is at risk Determine who is at risk Allocation of public health dollars Allocation of public health dollars Targeted prevention programs Targeted prevention programs Examine trends in the epidemic Examine trends in the epidemic Geography, race, sex, age Geography, race, sex, age Data analysis Data analysis Determining if prevention efforts succeed Determining if prevention efforts succeed Providing information to health departments, organizations, educational programs Providing information to health departments, organizations, educational programs Source: ODH Hepatitis Surveillance Program.

Know your ABCs Class A Diseases Class A Diseases (1) diseases of major public health concern because of the severity of disease or potential for epidemic spread; report by telephone immediately ex: Plague (1) diseases of major public health concern because of the severity of disease or potential for epidemic spread; report by telephone immediately ex: Plague (2) diseases of public health concern needing timely response because of potential for epidemic spread- report by the end of the next business day ex: Hepatitis A (2) diseases of public health concern needing timely response because of potential for epidemic spread- report by the end of the next business day ex: Hepatitis A (3) diseases of significant public health concern; report by the end of the work week ex: Hepatitis B, C, D, E (3) diseases of significant public health concern; report by the end of the work week ex: Hepatitis B, C, D, E Class B Diseases Class B Diseases Report by end of work week ex: influenza Report by end of work week ex: influenza Class C Diseases Class C Diseases Report outbreak or unusual incidence by end of next working day ex: Toxoplasmosis Report outbreak or unusual incidence by end of next working day ex: Toxoplasmosis Source: ODH Hepatitis Surveillance Program.

Hepatitis C in Ohio Health statistics can be found on the ODH website, Health statistics can be found on the ODH website, -Click on Health Statistics → Infectious Diseases → Reported Cases of Selected Notifiable Diseases- Ohio → Choose the year you are interested in reports available by year and month of report, patient age, gender, and county of residence reports available by year and month of report, patient age, gender, and county of residence Source: ODH Hepatitis Surveillance Program.

Describing Hepatitis C in Ohio Source: ODH Hepatitis Surveillance Program.

Hepatitis C (past or present) in: st Quarter 2005 Adams County340 Jackson County936 Lawrence County20218 Pike County954 Ross County Scioto County Ohio

Chronic hepatitis C reported to CDC by Ohio in 2004* *Numbers may be incomplete due to underreporting, reporting delays, and/or missing information Source: Ohio Department of Health Hepatitis Surveillance Program

The Ohio Department of Health HIV/HCV Integration Project Why integration????

The Ohio Department of Health HIV/HCV Integration Project The Ohio Department of Health HIV/HCV Integration Project Study Inception: May 2003 Study Inception: May 2003 Location: 15 HIV Counseling and Testing Sites throughout the state (will have 16 by the summer 2006) Location: 15 HIV Counseling and Testing Sites throughout the state (will have 16 by the summer 2006) Population: Individuals who seek HIV testing Population: Individuals who seek HIV testing Inclusion criteria: Presence of at least one of listed risk factors for HCV Inclusion criteria: Presence of at least one of listed risk factors for HCV Exclusion criteria: Insistence on anonymous testing Exclusion criteria: Insistence on anonymous testing

Site # of anti-HCV tests # of positive anti- HCV tests (%) Total tested who were confirmed positive for HCV (%) AVOC82 (25.0) Allen County19511 (5.6)10 (5.1) Canton City494 (8.2) Columbus City47159 (12.5)49 (10.4) Erie County342 (5.9)1 (2.9) Free Medical Clinic of Cleveland18717 (9.1)14 (7.5) Highland County Health Dept.83 (37.5)1 (12.5) J. Glen Smith Health Ctr68127 (4.0)18 (2.6) Mansfield/Richland County7910 (12.7) Meigs County Health Department40 (0.0) Newark City33830 (8.9)26 (7.7) Portsmouth City27833 (11.9)25 (9.0) Thomas McCafferty Health Ctr (3.0)26 (2.2) Washington County987 (7.1)6 (6.1) Youngstown City141 (7.1)0 (0.0) Total (6.6)192 (5.3) Summary of HCV Testing: 2005

Some words about risk assessment…….

ODH Hepatitis Contacts: Surveillance/ODRS: Surveillance/ODRS: Jessica Lietz, MPH Richard Thomas Perinatal Hepatitis B: Perinatal Hepatitis B: Ann Richardson, RN Hepatitis C Coordinator Hepatitis C Coordinator (also can answer clinical questions): Kathleen Koechlin, RN, MPH, PhD

Questions?????